Publications by authors named "Natalie Sacks"

Claim this Profile
M
Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab.
Saskia Jam Santegoets, Anita Gm Stam, Sinéad M Lougheed, Helen Gall, Karin Jooss, Natalie Sacks

J Immunother Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment.
Saskia J A M Santegoets, Anita G M Stam, Sinéad M Lougheed, Helen Gall, Petra E T Scholten, Natalie Sacks

Cancer Immunol Immunother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.
Alfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, Saskia J A M Santegoets, R Jeroen A van Moorselaar, Natalie Sacks

Lancet Oncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer.
Celestia S Higano, John M Corman, David C Smith, Arthur S Centeno, Christopher P Steidle, Natalie Sacks

Cancer· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.
Eric J Small, Natalie Sacks, John Nemunaitis, Walter J Urba, Eugene Dula

Clin Cancer Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical development paradigm for cancer vaccines and related biologics.
Axel Hoos, Giorgio Parmiani, Kristen Hege, Mario Sznol, Hans Loibner, Natalie Sacks

J Immunother· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer.
Jonathan W Simons, Natalie Sacks

Urol Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis